Ouyang Dan

Introduction

Ouyang Dan is a partner at the Beijing and Hong Kong offices of Wilson Sonsini Goodrich & Rosati, where she leads the capital markets practice in the Greater China area.

Since joining the firm in 2015, Ouyang has led the team to become a major Hong Kong and US capital markets powerhouse that competes head-to-head with other well-established players in the Greater China market in the sectors of technology, media and telecom, life sciences, healthcare, consumer products and education.

Ouyang’s experience includes US and Hong Kong equity offerings, Rule 144A and Regulation S bond offerings, special purpose acquisition companies and de-SPAC transactions, M&A and private equity transactions. She has an impressive track record in the US and Hong Kong equity offerings for major international issuers and underwriters.

Ouyang has represented corporate clients across a wide spectrum of industries, including technology, media and telecom, healthcare, education, consumer products and property management. In recent years, she advised a leading clear aligner treatment solution provider in China in its landmark Hong Kong IPO deal with a market cap reaching USD10 billion; and advised a number of leading tech companies’ US IPOs.

Ouyang is highly active and well recognised in market-leading work in the capital markets practice in Asia. Her recent recognitions and honours include CBLJ‘s “The A-List: China’s Elite Lawyers” from 2019 to 2022, ALB’s Asia’s Top 15 Female Lawyers in 2023, Super 50 TMT Lawyers in 2022 and 2023, Dealmakers of the Year in 2021 and 2022, China Top 15 Female Lawyers in 2021, IFLR1000’s “highly regarded lawyers” from 2021 to 2023, Chambers Global and Greater China Region Guides’ recommended capital market lawyer, and The Legal 500 Asia Pacific’s recommended capital market lawyer.